Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia
Arteaga, A.; Foradori, A.; Eyzaguirre, J.; Lira, P.; Vasquez, A.; Soto, S.; Alliende, M.E.; Guzman, L.
Revista Medica de Chile 98(10): 689-694
1970
ISSN/ISBN: 0034-9887 PMID: 4927028 Document Number: 27270
Document emailed within 1 workday
Related Documents
Zhu, L.; Wang, S.; Xu, R.; Zhong, J.; Liu, Y.; Mao, L. 1992: Clinical and experimental studies on tong yu ling in the treatment of diabetic hyperlipemia Journal of Traditional Chinese Medicine 12(3): 163-168Jansen, S.; Zambrana, J.L.; López Miranda, J.; Blanco, A.; Blanco, J.; Jiménez Perepérez, J.A.; Espino, A.; Pérez Jiménez, F. 1995: Possible relationship between overweightness and prevalence of hyperlipemia in the children of patients with heterozygote familial hypercholesterolemia and combined familial hyperlipemia Medicina Clinica 105(3): 85-88
Turcanu, V.; Bartl, F.; Fiat, F. 1970: Clinical and biological aspects of hyperlipemia Medicina Interna 22(4): 489-493
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Gries, F.A. 1975: Risk factor hyperlipemia: clinical aspects and therapy Die Medizinische Welt 26(36): 1590-1597
Schlierf, G. 1972: What is assured in the treatment of hyperlipemia? Der Internist 13(12): 503-506
Laberge, T.; Lepage, M. 1975: Guide to the selection of margarines in the treatment of hyperlipemia L'union Medicale du Canada 104(3): 444-446
Fukui, I. 1975: Clinical examination of hyperlipemia - normal and abnormal levels of blood lipid fractions Nihon Rinsho. Japanese Journal of Clinical Medicine 33(12): 3426-3438
Cockburn, I. 1986: Cyclosporine A: a clinical evaluation of drug interactions Transplantation Proceedings 18(6 Suppl 5: 50-55
Trusov, V.V.; Pimenóv, L.T.; Guseva, L.P. 1975: Clinical evaluation of a spasmolytic drug, dimidin Vrachebnoe Delo 8: 30-34
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Koszewski, W.; Bacia, T.; Rysz, A. 2003: Vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy. a 4-year follow-up evaluation of VNS treatment efficacy Neurologia i Neurochirurgia Polska 37(3): 573-586
Brea Hernando, A.J.; Villar Arias, M.A.; Mosquera Lozano, J.D.; Ramírez Alesón, M.V. 1996: Treatment of hyperlipemia: opinions of primary care physicians of the la Rioja region Medicina Clinica 106(11): 409-413
De Gennes, J.L. 1973: Biological exploration and basis of dietetic and pharmacological treatment for atheogenic hyperlipemia Annales de Cardiologie et d'Angeiologie 22(1): 33-40
Fracassi, M.U.; Delvecchio, F.R. 1971: A new antipsychotic drug: pimozide R 6238. Clinical evaluation Prensa Medica Argentina 58(28): 1444-1449
Osieka, R. 1984: Human malignant melanoma: preclinical and clinical drug evaluation Behring Institute Mitteilungen 74: 353-367
Keller, C.; Wolfram, G.; Zöllner, N. 1976: Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate Arzneimittel-Forschung 26(12): 2221-2224
Bolińska, H.; Kaluzna, J. 1970: Clinical evaluation of irrigor as a drug improving the coronary blood flow Wiadomosci Lekarskie 23(17): 1491-1493
Zanasi, R.; Volonteri, G.; Castaldi, D. 1971: Clinical evaluation of the use in arthrosis of a drug with antirheumatic and anti-inflammatory action Minerva Medica 62(3): 174-178
Taniguchi, K.; Nakamura, S.; Iesaka, Y.; Nitta, M.; Ito, H.; Kirigaya, H.; Takeuchi, J.; Fujiwara, H.; Iizumi, T.; Inada, M. 1985: Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan Clinical Therapeutics 7(5): 559-567